Phase I clinical and pharmacokinetic study of kahalalide F administered weekly as a 1-hour infusion to patients with advanced solid tumors

1. Pardo, B.
2. Paz-Ares, L.
3. Tabernero, J.
4. Ciruelos, E.
5. García, M.
6. Salazar, R.
7. López, A.
8. Blanco, M.
9. Nieto, A.
10. Jimeno, J.
11. Izquierdo, M.Á.
12. Trigo, J.M.